Journal of the National Comprehensive Cancer Network· 2020Q1· Review
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
- 1,383citations
- Q1SCImago
- 2020year
Short summary
Updated NCCN guidelines for head and neck cancers introduce new imaging recommendations and revised systemic therapy options for very advanced disease and salivary gland tumors.
AI-generated from the title and abstract; the full text is not read.
Key points
- New imaging recommendations are now part of the NCCN guidelines for head and neck cancers.
- Systemic therapy recommendations have been updated for very advanced head and neck cancers.
- Salivary gland tumors now have revised systemic therapy treatment recommendations.
- Treatment decisions are guided by disease site, stage, and pathology.
AI-generated from the title and abstract; the full text is not read.
Abstract
Treatment is complex for patients with head and neck (H&N) cancers with specific site of disease, stage, and pathologic findings guiding treatment decision-making. Treatment planning for H&N cancers involves a multidisciplinary team of experts. This article describes supportive care recommendations in the NCCN Guidelines for Head and Neck Cancers, as well as the rationale supporting a new section on imaging recommendations for patients with H&N cancers. This article also describes updates to treatment recommendations for patients with very advanced H&N cancers and salivary gland tumors, specifically systemic therapy recommendations.
The authors' abstract, as published at the source. Journal of the National Comprehensive Cancer Network, 2020 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Otorhinolaryngology
OtorhinolaryngologyMedicine